Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Int J Tuberc Lung Dis. 2015 Feb;19(2):163–171. doi: 10.5588/ijtld.14.0369

Table 1.

Treatment outcome definitions*

Treatment outcome Definitions
Cure Cure was defined as completion of treatment and >5 consecutive negative culture results in the final 12 months
of treatment. A patient was still considered cured If only one positive culture was reported during this time, was
clinically well, and this positive culture was followed by at least 3 consecutive negative cultures taken at least 30
days apart.
Treatment
completion
Treatment completion referred to completion of therapy but without bacteriologic documentation of cure.
Treatment success Treatment success has been defined as the percentage of patients in whom the treatment outcome was either
cured or completed. That is, “% successful = no. of patients cured + no. of patients completed treatment /Total
no. initiated treatment × 100”.
Treatment failure Treatment failure was defined as having more than one positive culture in the final 12 months of therapy, or if
any one of the final three cultures was positive, or if more than one drug in the treatment regimen was replaced,
or if treatment was terminated due to adverse events or no clinical improvement.
Default Default was defined as an interruption in treatment for ≥ 2 consecutive months for any reason.
Death Death was defined as all-cause mortality during MDR-TB treatment.
Unsuccessful
treatment
Unsuccessful treatment outcome has been defined as the percentage of patients in whom the treatment
outcome was died, defaulted, or failed treatment.
Transferred out A patient with MDR-TB who was transferred to another reporting and recording unit a year after study-
enrolment whose treatment outcome is unknown.
*

Treatment outcome definitions used are 2008 WHO definitions for the management of MDR-TB.17,18